SI2134353T1 - Dvofazni sestavek lipidnih veziklov in postopek za zdravljenje cervikalne displazije z intravaginalnim dajanjem - Google Patents
Dvofazni sestavek lipidnih veziklov in postopek za zdravljenje cervikalne displazije z intravaginalnim dajanjemInfo
- Publication number
- SI2134353T1 SI2134353T1 SI200831765A SI200831765A SI2134353T1 SI 2134353 T1 SI2134353 T1 SI 2134353T1 SI 200831765 A SI200831765 A SI 200831765A SI 200831765 A SI200831765 A SI 200831765A SI 2134353 T1 SI2134353 T1 SI 2134353T1
- Authority
- SI
- Slovenia
- Prior art keywords
- cervical dysplasia
- treating cervical
- vesicle composition
- intravaginal delivery
- biphasic lipid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90932407P | 2007-03-30 | 2007-03-30 | |
EP08733666.5A EP2134353B1 (en) | 2007-03-30 | 2008-03-27 | Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery |
PCT/CA2008/000563 WO2008119160A1 (en) | 2007-03-30 | 2008-03-27 | Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2134353T1 true SI2134353T1 (sl) | 2017-03-31 |
Family
ID=39807744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200831765A SI2134353T1 (sl) | 2007-03-30 | 2008-03-27 | Dvofazni sestavek lipidnih veziklov in postopek za zdravljenje cervikalne displazije z intravaginalnim dajanjem |
Country Status (18)
Country | Link |
---|---|
US (3) | US8945529B2 (sl) |
EP (1) | EP2134353B1 (sl) |
JP (1) | JP5587762B2 (sl) |
KR (1) | KR20090130081A (sl) |
AU (1) | AU2008234364B2 (sl) |
CA (1) | CA2681565C (sl) |
CY (1) | CY1118794T1 (sl) |
DK (1) | DK2134353T3 (sl) |
ES (1) | ES2617063T3 (sl) |
HR (1) | HRP20170250T1 (sl) |
HU (1) | HUE033256T2 (sl) |
LT (1) | LT2134353T (sl) |
MX (1) | MX2009010405A (sl) |
PL (1) | PL2134353T3 (sl) |
PT (1) | PT2134353T (sl) |
SI (1) | SI2134353T1 (sl) |
TW (1) | TWI440477B (sl) |
WO (1) | WO2008119160A1 (sl) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3008900B1 (fr) * | 2013-07-25 | 2018-03-30 | Centre Nat Rech Scient | Nanoparticules lipidiques multicompartimentees |
US8986732B2 (en) * | 2013-08-12 | 2015-03-24 | Helix Biopharma Corporation | Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery |
US10159646B2 (en) | 2013-08-12 | 2018-12-25 | Altum-Avro Pharma Partnership | Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery |
EP3041938A1 (en) | 2013-09-03 | 2016-07-13 | Moderna Therapeutics, Inc. | Circular polynucleotides |
US20150147382A1 (en) * | 2013-09-23 | 2015-05-28 | Exir Nano Sina Company | Topical liposomal compositions for delivering hydrophobic drugs and methods preparing same |
EP3625345B1 (en) | 2017-05-18 | 2023-05-24 | ModernaTX, Inc. | Modified messenger rna comprising functional rna elements |
US20180360757A1 (en) * | 2017-05-26 | 2018-12-20 | Altum Pharmaceuticals Inc. | Biphasix cannabinoid delivery |
MA50801A (fr) | 2017-11-22 | 2020-09-30 | Modernatx Inc | Polynucléotides codant pour la phénylalanine hydroxylase pour le traitement de la phénylcétonurie |
CA3079428A1 (en) | 2017-11-22 | 2019-05-31 | Modernatx, Inc. | Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders |
MA53609A (fr) | 2018-09-13 | 2021-07-21 | Modernatx Inc | Polynucléotides codant la glucose-6-phosphatase pour le traitement de la glycogénose |
AU2019339430A1 (en) | 2018-09-14 | 2021-04-29 | Modernatx, Inc. | Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide A1 for the treatment of Crigler-Najjar Syndrome |
MX2022003446A (es) * | 2019-09-23 | 2022-07-13 | Dds Res Inc | Composiciones de vesiculas lipidicas con agentes potenciadores de la penetracion. |
WO2022204390A1 (en) | 2021-03-24 | 2022-09-29 | Modernatx, Inc. | Lipid nanoparticles containing polynucleotides encoding phenylalanine hydroxylase and uses thereof |
WO2022204380A1 (en) | 2021-03-24 | 2022-09-29 | Modernatx, Inc. | Lipid nanoparticles containing polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits and uses thereof |
WO2022204371A1 (en) | 2021-03-24 | 2022-09-29 | Modernatx, Inc. | Lipid nanoparticles containing polynucleotides encoding glucose-6-phosphatase and uses thereof |
WO2022271776A1 (en) | 2021-06-22 | 2022-12-29 | Modernatx, Inc. | Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome |
WO2024026254A1 (en) | 2022-07-26 | 2024-02-01 | Modernatx, Inc. | Engineered polynucleotides for temporal control of expression |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5358708A (en) | 1993-01-29 | 1994-10-25 | Schering Corporation | Stabilization of protein formulations |
AU7343894A (en) * | 1993-07-28 | 1995-02-28 | University Of Saskatchewan | Biphasic multilamellar lipid vesicles |
IN184589B (sl) | 1996-10-16 | 2000-09-09 | Alza Corp | |
US5993852A (en) | 1997-08-29 | 1999-11-30 | Pharmaderm Laboratories Ltd. | Biphasic lipid vesicle composition for transdermal administration of an immunogen |
US6656499B1 (en) | 1999-11-12 | 2003-12-02 | Pharmaderm Laboratories, Ltd. | Composition for transdermal and dermal administration of interferon-α |
TWI272948B (en) | 2003-05-01 | 2007-02-11 | Ares Trading Sa | HSA-free stabilized interferon liquid formulations |
EP1576952A1 (en) | 2004-03-18 | 2005-09-21 | OctoPlus Technologies B.V. | Hydrogel microspheres with improved release profile |
-
2008
- 2008-03-27 CA CA2681565A patent/CA2681565C/en active Active
- 2008-03-27 LT LTEP08733666.5T patent/LT2134353T/lt unknown
- 2008-03-27 PL PL08733666T patent/PL2134353T3/pl unknown
- 2008-03-27 ES ES08733666.5T patent/ES2617063T3/es active Active
- 2008-03-27 US US12/532,752 patent/US8945529B2/en active Active
- 2008-03-27 SI SI200831765A patent/SI2134353T1/sl unknown
- 2008-03-27 MX MX2009010405A patent/MX2009010405A/es active IP Right Grant
- 2008-03-27 JP JP2010500036A patent/JP5587762B2/ja active Active
- 2008-03-27 DK DK08733666.5T patent/DK2134353T3/en active
- 2008-03-27 PT PT87336665T patent/PT2134353T/pt unknown
- 2008-03-27 KR KR1020097022186A patent/KR20090130081A/ko not_active Application Discontinuation
- 2008-03-27 EP EP08733666.5A patent/EP2134353B1/en active Active
- 2008-03-27 HU HUE08733666A patent/HUE033256T2/hu unknown
- 2008-03-27 WO PCT/CA2008/000563 patent/WO2008119160A1/en active Application Filing
- 2008-03-27 AU AU2008234364A patent/AU2008234364B2/en active Active
- 2008-03-28 TW TW097111592A patent/TWI440477B/zh active
-
2013
- 2013-03-22 US US13/849,455 patent/US20130224283A1/en not_active Abandoned
- 2013-03-22 US US13/849,451 patent/US20130216610A1/en not_active Abandoned
-
2017
- 2017-02-14 CY CY20171100200T patent/CY1118794T1/el unknown
- 2017-02-16 HR HRP20170250TT patent/HRP20170250T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
CA2681565C (en) | 2016-10-25 |
JP2010522698A (ja) | 2010-07-08 |
JP5587762B2 (ja) | 2014-09-10 |
EP2134353B1 (en) | 2016-11-16 |
AU2008234364A1 (en) | 2008-10-09 |
AU2008234364B2 (en) | 2013-10-17 |
EP2134353A1 (en) | 2009-12-23 |
DK2134353T3 (en) | 2017-02-20 |
PL2134353T3 (pl) | 2017-06-30 |
MX2009010405A (es) | 2010-02-03 |
TWI440477B (zh) | 2014-06-11 |
EP2134353A4 (en) | 2013-08-07 |
US8945529B2 (en) | 2015-02-03 |
ES2617063T3 (es) | 2017-06-15 |
US20130224283A1 (en) | 2013-08-29 |
US20130216610A1 (en) | 2013-08-22 |
CY1118794T1 (el) | 2017-07-12 |
WO2008119160A1 (en) | 2008-10-09 |
KR20090130081A (ko) | 2009-12-17 |
LT2134353T (lt) | 2017-03-27 |
CA2681565A1 (en) | 2008-10-09 |
HRP20170250T1 (hr) | 2017-04-07 |
PT2134353T (pt) | 2017-02-15 |
HUE033256T2 (hu) | 2017-11-28 |
US20100196453A1 (en) | 2010-08-05 |
TW200846030A (en) | 2008-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20170250T1 (hr) | Dvofazni pripravak lipidnih vezikula i postupak za liječenje cervikalne displazije intravaginalnom isporukom | |
IL291175A (en) | Compositions and methods for treating collagen-mediated diseases | |
IL216668A0 (en) | Pharmaceutical composition and treatment method for emergrncy contraception | |
EP2384221A4 (en) | METHOD FOR REDUCING COMPLAINTS DURING ELECTROSTIMULATION AND COMPOSITIONS AND DEVICE THEREFOR | |
EP2229171A4 (en) | METHOD AND COMPOSITIONS FOR TREATING POST-OPERATIVE PAIN WITH A LOCAL ANESTHETIC | |
AP3438A (en) | Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof | |
HK1220631A1 (zh) | 用於遞送治療劑的陰離子核心組合物以及製備和使用所述組合物的方法 | |
EP2497482A4 (en) | COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF INFLUENZA AVIRUSED INDUCED DISEASES | |
ZA201006293B (en) | Composition and method for seed treatment use | |
EP2473196A4 (en) | ADMINISTRATION OF SDF-1 FOR THE TREATMENT OF ISCHEMIC FABRICS | |
HUP0700369D0 (en) | Pharmaceutical compositions and method for treating schizofrenia | |
EP2211851A4 (en) | LAMININS, DERIVATIVES, COMPOSITIONS CONTAINING SAME, AND METHOD FOR THEIR THERAPEUTIC USE | |
EP2124991A4 (en) | PHARMACEUTICAL COMPOSITIONS AND METHOD FOR TREATING EFFECTIVE DYSFUNCTION | |
IL198723A0 (en) | Methods and compositions for therapeutic treatment | |
IL204728A0 (en) | Methods and compounds for treating retinol-related diseases | |
HK1162311A1 (en) | Intravaginal delivery system and process for manufacturing it | |
EP2329819A4 (en) | PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF SEXUALLY TRANSMITTED INFECTIONS | |
EP2294419A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CORNEAL INFLAMMATION | |
HK1145399A1 (en) | Pharmaceutical composition for treating hemorrhoids | |
SI2134742T1 (sl) | Imunogene zmesi za zdravljenje in prepreäśevanje ĺ˝ivalskih okuĺ˝b | |
ZA200807049B (en) | Compositions and methods for treating collagen-mediated diseases |